Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene Therapy
DNA and Cell Biology Reports · 2025
DOI: 10.1089/dcbr.2025.0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift DNA and Cell Biology Reports, 2025. Verfasst von Frank Martiniuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: JME Group Associates, Inc, Roseland, New Jersey, USA. Die Arbeit nennt 148 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- JME Group Associates, Inc, Roseland, New Jersey, USA.
- PsychoGenetics Center, Paramus, New Jersey, USA.
- Alexion. AstraZeneca Rare Diseases, Boston, Massachusetts, USA.
ORCID-Profile: Frank Martiniuk
Zitieren
APA
Martiniuk, F., Martiniuk, J., Mack, A., & Cheng, S. H. (2025). Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene Therapy. DNA and Cell Biology Reports. https://doi.org/10.1089/dcbr.2025.0025
Vancouver
Martiniuk F, Martiniuk J, Mack A, Cheng SH. Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene Therapy. DNA and Cell Biology Reports. 2025. doi:10.1089/dcbr.2025.0025
BibTeX
@article{Martiniuk2025,
author = {Martiniuk, Frank and Martiniuk, Justin and Mack, Adra and Cheng, Seng H},
title = {Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene Therapy},
journal = {DNA and Cell Biology Reports},
year = {2025},
doi = {10.1089/dcbr.2025.0025}
}
EUVIMED